Document Detail


Impaired baroreflex gain during pregnancy in conscious rats: role of brain insulin.
MedLine Citation:
PMID:  21149828     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pregnancy impairs baroreflex gain, but the mechanism is incompletely understood. To test the hypothesis that reductions in brain insulin contribute, we determined whether pregnant rats exhibit lower cerebrospinal fluid (CSF) insulin concentrations and whether intracerebroventricular infusion of insulin normalizes gain of baroreflex control of heart rate in conscious pregnant rats. CSF insulin was lower in pregnant (68 ± 21 pg/mL) compared to virgin (169 ± 25 pg/mL) rats (P < 0.05). Pregnancy reduced baroreflex gain (pregnant 2.4 ± 0.2 bpm/mm Hg, virgin 4.6 ± 0.3 bpm/mm Hg; P < 0.0001) and the maximum heart rate elicited by hypotension (pregnant 455 ± 15 bpm, virgin 507 ± 12 bpm; P = 0.01). Infusion of insulin (100 μU/min) intracerebroventricularly increased baroreflex gain in pregnant (2.4 ± 0.4 to 3.9 ± 0.5 bpm/mm Hg; P < 0.01) but not virgin (4.6 ± 0.4 to 4.2 ± 0.4 bpm/mm Hg; NS) rats. Maximum heart rate was not altered by intracerebroventricular insulin in either group. Interestingly, while in pregnant rats the baroreflex was unchanged by intracerebroventricular infusion of the artificial CSF vehicle, in virgin rats, vehicle infusion lowered baroreflex gain (4.7 ± 0.3 to 3.9 ± 0.3 bpm/mm Hg; P < 0.05) and the maximum baroreflex heart rate (495 ± 19 to 444 ± 21 bpm; P < 0.05). These data support the hypothesis that brain insulin is required to support optimal baroreflex function and that a decrease in brain insulin contributes to the fall in baroreflex gain during pregnancy.
Authors:
Afaf S Azar; Virginia L Brooks
Related Documents :
7671568 - Ventricular expression and circulating levels of insulin-like growth factor i in heart ...
9508068 - Nevo syndrome.
17645758 - Nocturnal secretion of growth hormone, noradrenaline, cortisol and insulin in cluster h...
6770998 - Regulation of estrogen-binding capacity by insulin in 7,12-dimethylbenz(a)anthracene-in...
640238 - Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory po...
21052978 - Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-12-13
Journal Detail:
Title:  Hypertension     Volume:  57     ISSN:  1524-4563     ISO Abbreviation:  Hypertension     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-20     Completed Date:  2011-04-22     Revised Date:  2012-02-02    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  United States    
Other Details:
Languages:  eng     Pagination:  283-8     Citation Subset:  IM    
Affiliation:
Department of Physiology and Pharmacology, Oregon Health & Science University, Portland, OR 97239, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Baroreflex / drug effects,  physiology*
Blood Pressure / physiology
Brain / metabolism,  physiology*
Consciousness
Female
Heart Rate / physiology
Hypoglycemic Agents / administration & dosage,  cerebrospinal fluid
Infusions, Intraventricular
Insulin / administration & dosage,  cerebrospinal fluid*
Male
Pregnancy
Rats
Rats, Sprague-Dawley
Grant Support
ID/Acronym/Agency:
HL088552/HL/NHLBI NIH HHS; R01 HL088552-01A1/HL/NHLBI NIH HHS; R01 HL088552-02/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Hypoglycemic Agents; 0/Insulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  C-reactive protein makes human endothelium stiff and tight.
Next Document:  Mild Hypothermia as a Cardioprotective Approach for Acute Myocardial Infarction: Laboratory to Clini...